1-3 of 3
William Trepicchio
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy

Clinical Trials & Observations
George Mulligan, David I. Lichter, Alessandra Di Bacco, Stephen J. Blakemore, Allison Berger, Erik Koenig, Hugues Bernard, William Trepicchio, Bin Li, Rachel Neuwirth, Nibedita Chattopadhyay, Joseph B. Bolen, Andrew J. Dorner, Helgi van de Velde, Deborah Ricci, Sundar Jagannath, James R. Berenson, Paul G. Richardson, Edward A. Stadtmauer, Robert Z. Orlowski, Sagar Lonial, Kenneth C. Anderson, Pieter Sonneveld, Jesús F. San Miguel, Dixie-Lee Esseltine, Matthew Schu
Journal: Blood
Blood (2014) 123 (5): 632–639.
https://doi.org/10.1182/blood-2013-05-504340
Published: 2014
Includes: Supplemental data
Journal Articles

Pharmacogenomics Study of Biological Pathways Related to Bortezomib Activity in Myeloma.

George Mulligan, Barb Bryant, Steven Roels, Andrew Bolt, Yan Meng, Erik Koenig, Anthony Boral, Dixie-Lee Esseltine, Kenneth A. Anderson, Peter Leif Bergsagel, Pieter Sonneveld, Annemiek Broyl, Constantine Mitsiades, Wee-Joo Chng, Paul G. Richardson, William Trepicchio
Journal: Blood
Blood (2007) 110 (11): 392.
https://doi.org/10.1182/blood.V110.11.392.392
Published: 2007
Journal Articles

Immunohistochemical Analyses for Potential Biomarkers of Bortezomib Activity in Mantle Cell Lymphoma from the PINNACLE Phase 2 Trial.

Andre Goy, Steven H. Bernstein, Alice McDonald, Michael D. Pickard, Mark D. Fleming, Barb Bryant, William Trepicchio, Richard I. Fisher, Anthony Boral, George Mulligan
Journal: Blood
Blood (2007) 110 (11): 2573.
https://doi.org/10.1182/blood.V110.11.2573.2573
Published: 2007